Ozempic
Semaglutide · Novo Nordisk
Ozempic (semaglutide) is a once-weekly injectable GLP-1 receptor agonist FDA-approved for type 2 diabetes. It helps lower blood sugar and has shown significant weight loss benefits. Many patients lose 10-15% of body weight.
FDA-Approved Uses
Ozempic is FDA-approved for the following conditions.
Dosing: 0.25mg, 0.5mg, or 1mg weekly injection
Average Cost
What you can expect to pay for Ozempic.
Need help affording Ozempic?
Answer 9 questions. See every program you're eligible for. Free.
Medicaid Coverage by State
Ozempic coverage status across all 51 states and territories.
| State | Medicaid | Medicare | Prior Auth |
|---|---|---|---|
| Alabama | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Alaska | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Arizona | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Arkansas | Covered (Prior Auth) | Covered (Prior Auth) | No |
| California | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Colorado | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Connecticut | Covered | Covered (Prior Auth) | No |
| Delaware | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| District of Columbia | Covered | Covered (Prior Auth) | No |
| Florida | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Georgia | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Hawaii | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Idaho | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Illinois | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Indiana | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Iowa | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Kansas | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Kentucky | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Louisiana | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Maine | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Maryland | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Massachusetts | Covered | Covered (Prior Auth) | No |
| Michigan | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Minnesota | Covered | Covered (Prior Auth) | No |
| Mississippi | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Missouri | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Montana | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Nebraska | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Nevada | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| New Hampshire | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| New Jersey | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| New Mexico | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| New York | Covered | Covered (Prior Auth) | No |
| North Carolina | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| North Dakota | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Ohio | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Oklahoma | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Oregon | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Pennsylvania | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Rhode Island | Covered | Covered (Prior Auth) | No |
| South Carolina | Covered (Prior Auth) | Covered (Prior Auth) | No |
| South Dakota | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Tennessee | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Texas | Covered (Prior Auth) | Covered (Prior Auth) | No |
| Utah | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Vermont | Covered | Covered (Prior Auth) | No |
| Virginia | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Washington | Covered | Covered (Prior Auth) | No |
| West Virginia | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Wisconsin | Covered (Prior Auth) | Covered (Prior Auth) | Required |
| Wyoming | Covered (Prior Auth) | Covered (Prior Auth) | No |
Patient Assistance Programs
Novo Nordisk offers savings programs that may reduce your cost to $0. Check eligibility below.
Check Eligibility at Novo Nordisk ↗Ozempic Side Effects
Common and serious side effects to discuss with your doctor.
⚡ Common Side Effects
- Nauseacommon
- Diarrheacommon
- Vomitingcommon
- Constipationcommon
- Abdominal paincommon
⚠️ Serious Side Effects
- Pancreatitisrare
- Thyroid tumorsrare
- Gallbladder problemsuncommon
Seek immediate medical attention if you experience any serious side effects.
Monitor Side Effects
Track Ozempic Side Effects with Helix
Oura-style monitoring for your Ozempic journey. Log side effects, see trends over time, and share reports with your doctor.
Try Helix Free →Free side effect tracking
Track Your Ozempic Journey
Meet Enzo — Your GLP-1 Companion
A virtual pet that grows as you track your Ozempic doses, weight, and meals. Stay motivated with streaks, milestones, and a buddy who celebrates your progress.
Try Enzo Free →Free on iOS and Android
Frequently Asked Questions
How much does Ozempic cost without insurance?
Ozempic costs approximately $935 per month without insurance. With insurance, copays range from $25 to $150 per month.
Does Medicaid cover Ozempic?
Medicaid coverage for Ozempic varies by state. Many states cover it with prior authorization. See the coverage table below for your state.
What are the side effects of Ozempic?
Common side effects include nausea, diarrhea, vomiting. Serious but rare side effects include pancreatitis and thyroid tumors.
What is the generic name for Ozempic?
The generic name for Ozempic is Semaglutide. It is manufactured by Novo Nordisk.
Get Your Free Benefits Report
Enter your email to receive a personalized report of every benefit program you may qualify for.
No spam. Unsubscribe anytime.
Compare Ozempic
Both contain semaglutide, but Ozempic is FDA-approved for diabetes while Wegovy is approved for weight management at a higher dose.
Ozempic vs MounjaroMounjaro's dual GIP/GLP-1 mechanism may produce greater weight loss than Ozempic's GLP-1-only approach.
Ozempic vs ZepboundOzempic treats diabetes while Zepbound targets weight loss. Zepbound (tirzepatide) may produce more weight loss.
Ozempic vs TrulicityBoth weekly GLP-1 injections for diabetes. Ozempic shows greater A1C reduction and weight loss in head-to-head trials.
Ozempic vs RybelsusBoth contain semaglutide — Ozempic is a weekly injection while Rybelsus is a daily oral tablet. The injection is generally more effective.
Ozempic vs SaxendaOzempic (weekly) produces more weight loss than Saxenda (daily). Saxenda was an earlier GLP-1 weight loss medication.
Ozempic vs VictozaBoth by Novo Nordisk. Ozempic is weekly and more effective, while Victoza is daily with longer safety track record.
Other GLP-1 Medications
FDA-approved weekly injection for chronic weight management
MounjaroDual-action GIP/GLP-1 injection for type 2 diabetes
ZepboundFDA-approved dual-action injection for chronic weight management
SaxendaDaily GLP-1 injection for weight management
RybelsusFirst oral GLP-1 tablet for type 2 diabetes
TrulicityWeekly GLP-1 injection for type 2 diabetes
VictozaDaily GLP-1 injection for type 2 diabetes